Loading…
Mobile-health Network Solutions is projected to rise to $3.45 by 2027, a +3% move from its current price of $3.35. MNDR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $3.17 | $3.35 | $3.54 | +0.03% |
| Jul 14 | $3.10 | $3.35 | $3.62 | +0.05% |
| Jul 15 | $3.05 | $3.35 | $3.69 | +0.08% |
| Jul 16 | $3.01 | $3.35 | $3.74 | +0.10% |
| Jul 17 | $2.97 | $3.35 | $3.79 | +0.13% |
| Jul 18 | $2.93 | $3.36 | $3.84 | +0.15% |
| Jul 19 | $2.90 | $3.36 | $3.88 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.90 | $3.36 | $3.88 | +0.18% |
| Week 2 | $2.74 | $3.36 | $4.12 | +0.36% |
| Week 3 | $2.62 | $3.37 | $4.33 | +0.53% |
| Week 4 | $2.53 | $3.37 | $4.50 | +0.71% |
| Week 5 | $2.45 | $3.38 | $4.67 | +0.89% |
| Week 6 | $2.38 | $3.39 | $4.82 | +1.07% |
| Week 7 | $2.31 | $3.39 | $4.97 | +1.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mobile-health Network Solutions (MNDR) is an investment holding company that provides telehealth solutions, primarily in Singapore. It operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices, and offers MaNaDr, a 360-degree healthcare ecosystem that connects users and service providers through the mobile app and website, as well as Internet search engines. The company provides teleconsultations, health check-ups, vaccinations, skin and aesthetics services, and other medical services, along with an online e-commerce platform for health-related products and a wholesale distribution channel via MaNaPharma.
It also runs MaNaCare, a corporate healthcare and wellness platform, and develops IT systems for mobile and web portals, while operating pharmacies, clinics, and drug stores and offering beauty and personal care services. The company was founded in 2009 and is headquartered in Singapore.
MNDR is a small-cap healthcare-focused stock with a current price of $3.28 and a market cap of $3.92M, ranking 5231 by market size. The stock sits in a sector that encompasses healthcare services, telehealth, and medical devices, with a broad range of services and platforms under the MaNa umbrella.
A major floor 86.0% below — a decisive break under it would weaken the trend.
The nearest floor, 15.8% below — buyers have tended to step in here.
The nearest ceiling, 39.3% above — a clean break opens room to run.
A major ceiling 66.1% above — clearing it would confirm fresh momentum.
Key MNDR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MNDR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.29 | Buy | $3.23 | Buy |
| MA 10 | $3.01 | Buy | $2.85 | Buy |
| MA 20 | $1.81 | Buy | $2.22 | Buy |
| MA 50 | $1.26 | Buy | $1.54 | Buy |
| MA 100 | $1.08 | Buy | $1.41 | Buy |
| MA 200 | $1.56 | Buy | $3.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 77.50 | Sell |
| Stoch RSI (14) | 80.24 | Sell |
| CCI (20) | 77.06 | Neutral |
| Williams %R (14) | -7.10 | Info |
| MACD (12,26,9) | 0.19 | Buy |
| ROC (12) | 489.79 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 92.90 | Sell |
| TRIX (15) | 6.97 | Buy |
| Awesome (5,34) | 1.92 | Buy |
| Ultimate (7,14,28) | 75.40 | Sell |
| Momentum (10) | 2.84 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 3.35 | Buy |
| ADX (14) | 45.76 | Buy |
| ATR (14) | 0.19 | Info |
Technically, the sentiment is neutral. The RSI14 is 80, indicating the stock is in overbought territory on a short horizon. The 50-day simple moving average sits at $1.02, while the 200-day simple moving average is $1.57, suggesting the near-term price could face resistance relative to longer-term moving averages.
Immediate support is at $0.47 and resistance at $3.57, with a 30-day price range spanning from $1.77 to $6.06, illustrating wide intraperiod volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.82 | $3.35 | $4.55 | 0% | Neutral | |
| $2.51 | $3.45 | $5.15 | +3% | Neutral | |
| $2.09 | $3.06 | $4.86 | -9% | Neutral | |
| $1.97 | $3.04 | $5.07 | -9% | Neutral | |
| $1.74 | $2.82 | $4.89 | -16% | Bearish | |
| $1.57 | $2.65 | $4.76 | -21% | Bearish | |
| $1.94 | $3.43 | $6.35 | +2% | Neutral | |
| $2.28 | $4.19 | $7.97 | +25% | Bullish | |
| $2.36 | $4.50 | $8.79 | +34% | Bullish | |
| $2.02 | $4.01 | $8.01 | +20% | Neutral | |
| $2.70 | $6.01 | $13.18 | +79% | Bullish | |
| $3.56 | $7.91 | $18.18 | +136% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.82 | $3.35 | $4.22 | +0.00% |
| August 2026 | $2.79 | $3.38 | $4.27 | +0.92% |
| September 2026 | $2.79 | $3.43 | $4.42 | +1.41% |
| October 2026 | $2.93 | $3.65 | $4.79 | +6.47% |
| November 2026 | $2.87 | $3.61 | $4.80 | -1.08% |
| December 2026 | $2.66 | $3.38 | $4.55 | -6.48% |
Click any year to see its month-by-month MNDR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MNDR to range from $2.82 to $4.55 through 2026. The $3.35 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The MNDR price prediction for 2027 points to an average of $3.45 (low $2.51, high $5.15) — a potential gain of +3% on today's $3.35. A consolidation phase looks the most probable path here.
In 2028, MNDR is projected to trade between $2.09 and $4.86, averaging $3.06 — a potential decline of -9% from today's $3.35. That is -11% versus the projected 2027 average. Price action looks broadly range-bound.
Mobile-health Network Solutions's 2029 outlook centres on $3.04, within a $1.97 to $5.07 range. That is 0% versus the projected 2028 average. That marks a -9% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, MNDR could reach as high as $4.89, with a base case around $2.82 and support toward $1.74 — roughly -16% from $3.35. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect MNDR to range from $1.57 to $4.76 through 2031. The $2.65 average target implies a -21% move from current prices. That is -6% versus the projected 2030 average. Expect choppier, lower action through this leg of the cycle.
The MNDR price prediction for 2032 points to an average of $3.43 (low $1.94, high $6.35) — a potential gain of +2% on today's $3.35. Price action looks broadly range-bound.
In 2033, MNDR is projected to trade between $2.28 and $7.97, averaging $4.19 — a potential gain of +25% from today's $3.35. That is up +22% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Mobile-health Network Solutions's 2034 outlook centres on $4.50, within a $2.36 to $8.79 range. That is up +8% on the projected 2033 average. That marks a +34% change versus current levels. Momentum favours further upside here.
By 2035, MNDR could reach as high as $8.01, with a base case around $4.01 and support toward $2.02 — roughly +20% from $3.35. A consolidation phase looks the most probable path here.
Expect MNDR to range from $2.70 to $13.18 through 2040. The $6.01 average target implies a +79% move from current prices. That is up +50% on the projected 2035 average. Momentum favours further upside here.
The MNDR price prediction for 2050 points to an average of $7.91 (low $3.56, high $18.18) — a potential gain of +136% on today's $3.35. Buyers look set to stay in control over this stretch.
Investing $1,000 in MNDR today (≈ 298.507463 MNDR) could be worth
$2,359.77
+$1,359.77 (+136%) by 2050 · US Dollar
Based on the average projected MNDR price of $7.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MNDRwould be worth at today's price.
$1,000 invested in MNDR on Jul 10, 2025 (≈ 173.913043 MNDR) would be worth
$582.61
-$417.39 (-41.7%) today · 0.58× · US Dollar
Based on a MNDR entry price of $5.75 vs. today's $3.35.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.28 | $1,021.34 | +2.1% |
| 1 month ago | $0.7 | $4,785.71 | +378.6% |
| 3 months ago | $0.828 | $4,045.89 | +304.6% |
| 6 months ago | $1 | $3,350 | +235.0% |
| 1 year ago | $5.75 | $582.61 | -41.7% |
| All time (2.2y) ago | $268 | $12.5 | -98.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MNDR forecast.
Our base-case forecast reaches $6.70 around 2050.
Implied market cap at $6.70: $5.95M
Longer-term forecasts show a mixed trajectory with notable upside later in the horizon. For 2030 the average price is projected at $2.74 with a -16.4% ROI and a Bearish sentiment, followed by 2031 at $2.46 (ROI -25.1%, Bearish). The outlook improves in 2033 to an average of $4.11 (ROI 25.3%, Bullish) and 2034 to $4.23 (ROI 28.9%, Bullish).
By 2040 the average price is forecast at $5.69 with a strong 73.5% ROI and a Bullish sentiment, and by 2050 the average is expected to reach $7.38 with a 125.2% ROI and a Bullish sentiment. These projections show a transition from mid-stage bearish periods to substantial long-run upside, though there is inherent uncertainty and year-to-year variability in the forecasts.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2.74 with a -16.4% ROI and a Bearish sentiment. The projected min and max are $1.69 and $4.76, respectively.
Forecasts indicate mixed signals: negative ROIs in 2030 and 2031, but turning positive later with 2033 at 25.3% and 2034 at 28.9%. Long-run upside is indicated with 2040 at 73.5% ROI and 2050 at 125.2% ROI, though these are estimates and not guarantees.
Yes, the forecast for 2040 shows a max of $12.50, and the 2050 max is $16.99, indicating potential higher-price scenarios over the longer term.
For 2026, the average price is $3.28 with a min of $0.47 and a max of $4.42; the ROI is 0% and the sentiment is Neutral.
The RSI14 is 80, indicating the stock is in overbought territory from a technical perspective, while the overall sentiment remains Neutral.
Mobile-health Network Solutions Community Discussion
0Share your Mobile-health Network Solutions price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.